| 0 |
APPLICATION SITE JOINT MOVEMENT IMPAIRMENT |
1 |
0.5000 |
| 1 |
BOOSTER DOSE MISSED |
1 |
0.2500 |
| 2 |
DELUSIONAL DISORDER, GRANDIOSE TYPE |
1 |
0.1429 |
| 3 |
FAILED EXAMINATIONS |
2 |
0.1176 |
| 4 |
IMPERFORATE HYMEN |
1 |
0.0833 |
| 5 |
PRODUCT ADMINISTERED BY WRONG PERSON |
29 |
0.0759 |
| 6 |
EGOCENTRISM |
2 |
0.0714 |
| 7 |
TACITURNITY |
6 |
0.0682 |
| 8 |
DELINQUENCY |
1 |
0.0526 |
| 9 |
SCHIZOAFFECTIVE DISORDER DEPRESSIVE TYPE |
2 |
0.0476 |
| 10 |
SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE |
10 |
0.0435 |
| 11 |
INJECTED LIMB MOBILITY DECREASED |
6 |
0.0420 |
| 12 |
ALEXITHYMIA |
2 |
0.0400 |
| 13 |
DEATH OF COMPANION |
1 |
0.0385 |
| 14 |
PERSONAL RELATIONSHIP ISSUE |
23 |
0.0344 |
| 15 |
LACK OF ADMINISTRATION SITE ROTATION |
9 |
0.0295 |
| 16 |
INJECTION SITE MOVEMENT IMPAIRMENT |
3 |
0.0234 |
| 17 |
EXERCISE TOLERANCE INCREASED |
1 |
0.0233 |
| 18 |
NEEDLE ISSUE |
667 |
0.0229 |
| 19 |
ALCOHOL TEST POSITIVE |
1 |
0.0213 |
| 20 |
PSYCHIATRIC DECOMPENSATION |
38 |
0.0194 |
| 21 |
SOLILOQUY |
16 |
0.0185 |
| 22 |
SUSPICIOUSNESS |
13 |
0.0185 |
| 23 |
PRODUCT SUBSTITUTION ERROR |
2 |
0.0171 |
| 24 |
INJECTION SITE NERVE DAMAGE |
4 |
0.0167 |
| 25 |
ALCOHOLIC HANGOVER |
1 |
0.0164 |
| 26 |
INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT |
1 |
0.0154 |
| 27 |
GASTROINTESTINAL NEUROENDOCRINE TUMOUR |
1 |
0.0154 |
| 28 |
FEAR OF CROWDED PLACES |
1 |
0.0149 |
| 29 |
HOSTILITY |
37 |
0.0145 |
| 30 |
CAFFEINE CONSUMPTION |
1 |
0.0145 |
| 31 |
CONSTRICTED AFFECT |
1 |
0.0143 |
| 32 |
IMPERCEPTION |
1 |
0.0141 |
| 33 |
EXHIBITIONISM |
1 |
0.0139 |
| 34 |
INJECTION SITE CYST |
4 |
0.0137 |
| 35 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
6 |
0.0129 |
| 36 |
PSYCHOTIC SYMPTOM |
26 |
0.0126 |
| 37 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
68 |
0.0123 |
| 38 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
219 |
0.0119 |
| 39 |
HALLUCINATION, AUDITORY |
175 |
0.0110 |
| 40 |
SYRINGE ISSUE |
174 |
0.0099 |
| 41 |
IRREGULAR SLEEP WAKE RHYTHM DISORDER |
2 |
0.0099 |
| 42 |
IDEAS OF REFERENCE |
1 |
0.0098 |
| 43 |
LACK OF INJECTION SITE ROTATION |
17 |
0.0097 |
| 44 |
CONDUCT DISORDER |
2 |
0.0097 |
| 45 |
POOR PERSONAL HYGIENE |
5 |
0.0097 |
| 46 |
MALABSORPTION FROM INJECTION SITE |
3 |
0.0097 |
| 47 |
SUBSTANCE USE |
15 |
0.0096 |
| 48 |
PRODUCT RECONSTITUTION ISSUE |
3 |
0.0095 |
| 49 |
SCHIZOPHRENIA |
104 |
0.0085 |
| 50 |
IRON METABOLISM DISORDER |
1 |
0.0084 |
| 51 |
ANTISOCIAL PERSONALITY DISORDER |
1 |
0.0078 |
| 52 |
MANUFACTURING MATERIALS ISSUE |
3 |
0.0074 |
| 53 |
SOCIAL AVOIDANT BEHAVIOUR |
43 |
0.0074 |
| 54 |
SCHIZOAFFECTIVE DISORDER |
13 |
0.0073 |
| 55 |
HALLUCINATION, OLFACTORY |
3 |
0.0069 |
| 56 |
GAMBLING |
8 |
0.0069 |
| 57 |
EMOTIONAL POVERTY |
12 |
0.0068 |
| 58 |
PERSECUTORY DELUSION |
17 |
0.0068 |
| 59 |
PRODUCT LEAKAGE |
38 |
0.0068 |
| 60 |
DELUSIONAL DISORDER, UNSPECIFIED TYPE |
5 |
0.0067 |
| 61 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0066 |
| 62 |
HISTRIONIC PERSONALITY DISORDER |
1 |
0.0066 |
| 63 |
FACTITIOUS DISORDER |
1 |
0.0066 |
| 64 |
BRUCELLOSIS |
1 |
0.0066 |
| 65 |
FEAR-RELATED AVOIDANCE OF ACTIVITIES |
1 |
0.0066 |
| 66 |
ATTENTION-SEEKING BEHAVIOUR |
1 |
0.0064 |
| 67 |
DUPLICATE THERAPY ERROR |
2 |
0.0062 |
| 68 |
PRESSURE OF SPEECH |
4 |
0.0062 |
| 69 |
CYCLOTHYMIC DISORDER |
1 |
0.0061 |
| 70 |
HAND-EYE COORDINATION IMPAIRED |
1 |
0.0059 |
| 71 |
PSYCHOTIC BEHAVIOUR |
6 |
0.0059 |
| 72 |
ALCOHOL USE DISORDER |
1 |
0.0058 |
| 73 |
INJECTION SITE HYPOAESTHESIA |
8 |
0.0056 |
| 74 |
THERAPEUTIC RESPONSE SHORTENED |
182 |
0.0055 |
| 75 |
THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0054 |
| 76 |
PRODUCT CLOSURE ISSUE |
3 |
0.0054 |
| 77 |
AKATHISIA |
73 |
0.0053 |
| 78 |
COMPULSIVE SHOPPING |
11 |
0.0053 |
| 79 |
PARANOIA |
91 |
0.0053 |
| 80 |
HYPOMETABOLISM |
2 |
0.0052 |
| 81 |
IMPRISONMENT |
9 |
0.0051 |
| 82 |
INAPPROPRIATE AFFECT |
8 |
0.0050 |
| 83 |
EXCESSIVE MASTURBATION |
1 |
0.0048 |
| 84 |
LACTATION INSUFFICIENCY |
1 |
0.0048 |
| 85 |
DELUSION |
75 |
0.0048 |
| 86 |
CRYSTAL ARTHROPATHY |
1 |
0.0048 |
| 87 |
DISSOCIATIVE IDENTITY DISORDER |
1 |
0.0048 |
| 88 |
TOBACCO USER |
7 |
0.0047 |
| 89 |
GENITAL DISORDER MALE |
1 |
0.0047 |
| 90 |
BELLIGERENCE |
2 |
0.0047 |
| 91 |
BINGE EATING |
5 |
0.0046 |
| 92 |
WRONG DEVICE USED |
3 |
0.0046 |
| 93 |
SOCIAL ANXIETY DISORDER |
3 |
0.0046 |
| 94 |
FACIAL SPASM |
5 |
0.0045 |
| 95 |
HYPERSEXUALITY |
8 |
0.0044 |
| 96 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
7 |
0.0044 |
| 97 |
TACHYPHRENIA |
15 |
0.0043 |
| 98 |
PRODUCT ADMINISTRATION ERROR |
86 |
0.0043 |
| 99 |
INJECTION SITE GRANULOMA |
1 |
0.0042 |
| 100 |
INJECTION SITE INDURATION |
54 |
0.0042 |
| 101 |
LACTATION DISORDER |
2 |
0.0041 |
| 102 |
PSYCHOTIC DISORDER |
120 |
0.0041 |
| 103 |
HYPONATRAEMIC SEIZURE |
1 |
0.0039 |
| 104 |
INJECTION SITE MASS |
145 |
0.0039 |
| 105 |
CORONAVIRUS TEST POSITIVE |
4 |
0.0039 |
| 106 |
VICTIM OF SEXUAL ABUSE |
2 |
0.0038 |
| 107 |
INJECTION SITE DISCOMFORT |
40 |
0.0038 |
| 108 |
CRIME |
1 |
0.0038 |
| 109 |
HYPERMETABOLISM |
2 |
0.0038 |
| 110 |
ANTIPSYCHOTIC DRUG LEVEL DECREASED |
2 |
0.0038 |
| 111 |
IMPATIENCE |
7 |
0.0037 |
| 112 |
COMPULSIVE SEXUAL BEHAVIOUR |
3 |
0.0037 |
| 113 |
TONGUE MOVEMENT DISTURBANCE |
3 |
0.0035 |
| 114 |
MANIA |
57 |
0.0035 |
| 115 |
FLAT AFFECT |
8 |
0.0035 |
| 116 |
HOMICIDAL IDEATION |
14 |
0.0034 |
| 117 |
LIBIDO INCREASED |
7 |
0.0034 |
| 118 |
GAMBLING DISORDER |
9 |
0.0033 |
| 119 |
HYPERPHAGIA |
13 |
0.0033 |
| 120 |
FEAR OF EATING |
1 |
0.0032 |
| 121 |
ECHOLALIA |
1 |
0.0031 |
| 122 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
33 |
0.0031 |
| 123 |
HAEMATOLOGY TEST ABNORMAL |
1 |
0.0031 |
| 124 |
ASOCIAL BEHAVIOUR |
1 |
0.0031 |
| 125 |
ANOREXIA NERVOSA |
1 |
0.0031 |
| 126 |
INJECTION SITE HYPERTROPHY |
1 |
0.0031 |
| 127 |
BENIGN HYDATIDIFORM MOLE |
1 |
0.0030 |
| 128 |
THEFT |
2 |
0.0030 |
| 129 |
COMPULSIONS |
2 |
0.0030 |
| 130 |
ANTISOCIAL BEHAVIOUR |
3 |
0.0030 |
| 131 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
139 |
0.0030 |
| 132 |
BOREDOM |
1 |
0.0029 |
| 133 |
ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC |
2 |
0.0029 |
| 134 |
HALLUCINATIONS, MIXED |
12 |
0.0029 |
| 135 |
INJECTION SITE SCAR |
8 |
0.0028 |
| 136 |
DISSOCIATIVE DISORDER |
2 |
0.0028 |
| 137 |
JUDGEMENT IMPAIRED |
4 |
0.0028 |
| 138 |
BIPOLAR I DISORDER |
6 |
0.0027 |
| 139 |
GRANDIOSITY |
1 |
0.0027 |
| 140 |
LEGAL PROBLEM |
2 |
0.0027 |
| 141 |
PSYCHIATRIC SYMPTOM |
20 |
0.0027 |
| 142 |
SKIN STRIAE |
4 |
0.0027 |
| 143 |
BODY DYSMORPHIC DISORDER |
1 |
0.0027 |
| 144 |
NEGATIVISM |
2 |
0.0026 |
| 145 |
IMPAIRED REASONING |
1 |
0.0026 |
| 146 |
HYPEREMESIS GRAVIDARUM |
1 |
0.0026 |
| 147 |
DAYDREAMING |
4 |
0.0026 |
| 148 |
MORBID THOUGHTS |
3 |
0.0026 |
| 149 |
LOGORRHOEA |
9 |
0.0026 |
| 150 |
INTRUSIVE THOUGHTS |
3 |
0.0025 |
| 151 |
GRANULOCYTE COUNT INCREASED |
1 |
0.0025 |
| 152 |
DELUSIONAL PERCEPTION |
1 |
0.0024 |
| 153 |
DELUSIONAL DISORDER, PERSECUTORY TYPE |
1 |
0.0024 |
| 154 |
INCORRECT PRODUCT DOSAGE FORM ADMINISTERED |
1 |
0.0024 |
| 155 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 156 |
RESTLESSNESS |
86 |
0.0023 |
| 157 |
OCULOGYRIC CRISIS |
5 |
0.0023 |
| 158 |
DEREALISATION |
5 |
0.0023 |
| 159 |
LOSS OF EMPLOYMENT |
7 |
0.0023 |
| 160 |
UNDERDOSE |
169 |
0.0023 |
| 161 |
INJECTION SITE INDENTATION |
5 |
0.0023 |
| 162 |
BULIMIA NERVOSA |
1 |
0.0023 |
| 163 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0023 |
| 164 |
HOMELESS |
1 |
0.0022 |
| 165 |
ENLARGED UVULA |
1 |
0.0022 |
| 166 |
DELUSION OF GRANDEUR |
1 |
0.0022 |
| 167 |
INFERTILITY MALE |
1 |
0.0022 |
| 168 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
14 |
0.0022 |
| 169 |
DISORGANISED SPEECH |
4 |
0.0022 |
| 170 |
EATING DISORDER SYMPTOM |
1 |
0.0022 |
| 171 |
FEELING OF DESPAIR |
10 |
0.0021 |
| 172 |
IMPULSIVE BEHAVIOUR |
8 |
0.0021 |
| 173 |
THERAPEUTIC RESPONSE INCREASED |
2 |
0.0021 |
| 174 |
APATHY |
31 |
0.0021 |
| 175 |
COMMUNICATION DISORDER |
8 |
0.0021 |
| 176 |
SUBSTANCE ABUSE |
17 |
0.0021 |
| 177 |
HELPLESSNESS |
1 |
0.0021 |
| 178 |
HYPERVIGILANCE |
2 |
0.0021 |
| 179 |
EXERCISE LACK OF |
1 |
0.0021 |
| 180 |
NEGATIVE THOUGHTS |
6 |
0.0020 |
| 181 |
INJECTION SITE ABSCESS |
5 |
0.0020 |
| 182 |
HYPOHIDROSIS |
1 |
0.0020 |
| 183 |
INJECTION SITE PARAESTHESIA |
3 |
0.0020 |
| 184 |
KELOID SCAR |
1 |
0.0019 |
| 185 |
VIOLENCE-RELATED SYMPTOM |
3 |
0.0019 |
| 186 |
AXILLARY MASS |
2 |
0.0019 |
| 187 |
FLIGHT OF IDEAS |
1 |
0.0019 |
| 188 |
FOCAL NODULAR HYPERPLASIA |
1 |
0.0019 |
| 189 |
WRONG PRODUCT ADMINISTERED |
13 |
0.0019 |
| 190 |
BODY TEMPERATURE FLUCTUATION |
4 |
0.0019 |
| 191 |
PHYSICAL ASSAULT |
4 |
0.0019 |
| 192 |
PERSONALITY DISORDER |
5 |
0.0019 |
| 193 |
DRUG SCREEN POSITIVE |
15 |
0.0019 |
| 194 |
ALCOHOL USE |
7 |
0.0019 |
| 195 |
GRIEF REACTION |
1 |
0.0019 |
| 196 |
NEUROMYOPATHY |
2 |
0.0019 |
| 197 |
ALCOHOL ABUSE |
5 |
0.0019 |
| 198 |
AUTOSCOPY |
1 |
0.0019 |
| 199 |
SOMATIC SYMPTOM DISORDER |
2 |
0.0019 |
| 200 |
RESTLESS LEGS SYNDROME |
33 |
0.0018 |
| 201 |
DRUG ADMINISTRATION ERROR |
54 |
0.0018 |
| 202 |
EUPHORIC MOOD |
18 |
0.0018 |
| 203 |
BIPOLAR DISORDER |
19 |
0.0017 |
| 204 |
DISTRACTIBILITY |
2 |
0.0017 |
| 205 |
FLASHBACK |
1 |
0.0017 |
| 206 |
AGITATION |
126 |
0.0017 |
| 207 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
4 |
0.0017 |
| 208 |
TERMINAL INSOMNIA |
3 |
0.0017 |
| 209 |
ADENOMYOSIS |
1 |
0.0017 |
| 210 |
ABNORMAL BEHAVIOUR |
67 |
0.0017 |
| 211 |
DERMATILLOMANIA |
1 |
0.0017 |
| 212 |
OBSESSIVE THOUGHTS |
3 |
0.0017 |
| 213 |
TIC |
9 |
0.0016 |
| 214 |
SLOW SPEECH |
4 |
0.0016 |
| 215 |
DROOLING |
11 |
0.0016 |
| 216 |
DRUG LEVEL CHANGED |
1 |
0.0016 |
| 217 |
THINKING ABNORMAL |
29 |
0.0016 |
| 218 |
CONVERSION DISORDER |
3 |
0.0015 |
| 219 |
SLOW RESPONSE TO STIMULI |
2 |
0.0015 |
| 220 |
JOB DISSATISFACTION |
1 |
0.0015 |
| 221 |
FEELINGS OF WORTHLESSNESS |
2 |
0.0015 |
| 222 |
ENERGY INCREASED |
9 |
0.0015 |
| 223 |
INCREASED APPETITE |
29 |
0.0015 |
| 224 |
HALLUCINATION, VISUAL |
32 |
0.0015 |
| 225 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
2 |
0.0015 |
| 226 |
HALLUCINATION, TACTILE |
1 |
0.0015 |
| 227 |
BODY MASS INDEX INCREASED |
2 |
0.0015 |
| 228 |
AGGRESSION |
74 |
0.0015 |
| 229 |
IMPULSE-CONTROL DISORDER |
3 |
0.0015 |
| 230 |
IMPAIRED SELF-CARE |
3 |
0.0014 |
| 231 |
SELF-INJURIOUS IDEATION |
6 |
0.0014 |
| 232 |
PRODUCT EXPIRATION DATE ISSUE |
2 |
0.0014 |
| 233 |
TREATMENT NONCOMPLIANCE |
78 |
0.0014 |
| 234 |
INJECTION SITE PAIN |
436 |
0.0014 |
| 235 |
GLASSY EYES |
1 |
0.0014 |
| 236 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 237 |
FEAR OF INJECTION |
10 |
0.0014 |
| 238 |
PRODUCT DISTRIBUTION ISSUE |
13 |
0.0014 |
| 239 |
HALLUCINATION |
105 |
0.0014 |
| 240 |
ANGER |
47 |
0.0014 |
| 241 |
PRODUCT PHYSICAL ISSUE |
28 |
0.0014 |
| 242 |
LIQUID PRODUCT PHYSICAL ISSUE |
10 |
0.0014 |
| 243 |
DRUG-DISEASE INTERACTION |
1 |
0.0014 |
| 244 |
CORONAVIRUS INFECTION |
9 |
0.0014 |
| 245 |
BLUNTED AFFECT |
1 |
0.0014 |
| 246 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
3 |
0.0013 |
| 247 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
23 |
0.0013 |
| 248 |
INDIFFERENCE |
1 |
0.0013 |
| 249 |
OFF LABEL USE |
1147 |
0.0013 |
| 250 |
GASTROINTESTINAL SURGERY |
1 |
0.0013 |
| 251 |
PRODUCT DEPOSIT |
2 |
0.0013 |
| 252 |
SUSPECTED SUICIDE |
6 |
0.0013 |
| 253 |
INJECTION SITE NODULE |
14 |
0.0013 |
| 254 |
EYELID FUNCTION DISORDER |
1 |
0.0013 |
| 255 |
WEIGHT ABNORMAL |
3 |
0.0012 |
| 256 |
PREGNANCY |
25 |
0.0012 |
| 257 |
OBSESSIVE-COMPULSIVE DISORDER |
10 |
0.0012 |
| 258 |
DISINHIBITION |
2 |
0.0012 |
| 259 |
FEAR OF FALLING |
1 |
0.0012 |
| 260 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 261 |
NEUROLEPTIC MALIGNANT SYNDROME |
14 |
0.0012 |
| 262 |
TRISMUS |
6 |
0.0012 |
| 263 |
PRIAPISM |
4 |
0.0012 |
| 264 |
GENITAL BURNING SENSATION |
1 |
0.0012 |
| 265 |
HYPERSOMNIA |
33 |
0.0011 |
| 266 |
SEDATION |
30 |
0.0011 |
| 267 |
EMOTIONAL DISORDER |
35 |
0.0011 |
| 268 |
JAW OPERATION |
1 |
0.0011 |
| 269 |
INDURATION |
2 |
0.0011 |
| 270 |
DECREASED ACTIVITY |
12 |
0.0011 |
| 271 |
BONE CONTUSION |
1 |
0.0011 |
| 272 |
DISTURBANCE IN SEXUAL AROUSAL |
1 |
0.0011 |
| 273 |
HYPOMANIA |
4 |
0.0011 |
| 274 |
MUSCLE TWITCHING |
25 |
0.0011 |
| 275 |
HUNGER |
15 |
0.0011 |
| 276 |
SKIN HYPERTROPHY |
3 |
0.0011 |
| 277 |
INJECTION SITE ULCER |
1 |
0.0011 |
| 278 |
BLOOD PROLACTIN INCREASED |
5 |
0.0011 |
| 279 |
INJECTION SITE SCAB |
1 |
0.0010 |
| 280 |
IRRITABILITY |
62 |
0.0010 |
| 281 |
INJECTION SITE WARMTH |
21 |
0.0010 |
| 282 |
BRAIN HYPOXIA |
1 |
0.0010 |
| 283 |
DROWNING |
1 |
0.0010 |
| 284 |
GASTRIC PH DECREASED |
1 |
0.0010 |
| 285 |
WEIGHT INCREASED |
218 |
0.0010 |
| 286 |
BLADDER DYSFUNCTION |
1 |
0.0010 |
| 287 |
TONGUE BITING |
2 |
0.0010 |
| 288 |
SOCIAL PROBLEM |
4 |
0.0010 |
| 289 |
CATATONIA |
5 |
0.0010 |
| 290 |
SLEEP TERROR |
4 |
0.0009 |
| 291 |
HOSPITALISATION |
145 |
0.0009 |
| 292 |
DYSKINESIA |
38 |
0.0009 |
| 293 |
CLAUSTROPHOBIA |
1 |
0.0009 |
| 294 |
ACARODERMATITIS |
1 |
0.0009 |
| 295 |
IMMEDIATE POST-INJECTION REACTION |
1 |
0.0009 |
| 296 |
PRODUCT LOT NUMBER ISSUE |
2 |
0.0009 |
| 297 |
COGNITIVE DISORDER |
42 |
0.0009 |
| 298 |
DEMENTIA WITH LEWY BODIES |
1 |
0.0009 |
| 299 |
TEMPERATURE REGULATION DISORDER |
2 |
0.0009 |
| 300 |
POST-TRAUMATIC STRESS DISORDER |
6 |
0.0009 |
| 301 |
INCORRECT DOSE ADMINISTERED |
202 |
0.0009 |
| 302 |
DRUG EFFECT VARIABLE |
1 |
0.0009 |
| 303 |
SLUGGISHNESS |
9 |
0.0009 |
| 304 |
IMPAIRED DRIVING ABILITY |
10 |
0.0009 |
| 305 |
EYE MOVEMENT DISORDER |
6 |
0.0009 |
| 306 |
READING DISORDER |
2 |
0.0009 |
| 307 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 308 |
DYSLEXIA |
1 |
0.0009 |
| 309 |
FRUSTRATION TOLERANCE DECREASED |
7 |
0.0009 |
| 310 |
INCONTINENCE |
9 |
0.0009 |
| 311 |
TARDIVE DYSKINESIA |
24 |
0.0008 |
| 312 |
DECREASED INTEREST |
5 |
0.0008 |
| 313 |
GLUCOSE TOLERANCE IMPAIRED |
5 |
0.0008 |
| 314 |
DRUG USE DISORDER |
7 |
0.0008 |
| 315 |
STARING |
2 |
0.0008 |
| 316 |
PRODUCT DOSE OMISSION |
53 |
0.0008 |
| 317 |
INJECTION SITE INFLAMMATION |
4 |
0.0008 |
| 318 |
SCREAMING |
5 |
0.0008 |
| 319 |
THIRST |
14 |
0.0008 |
| 320 |
CLAVICLE FRACTURE |
3 |
0.0008 |
| 321 |
ADNEXA UTERI PAIN |
1 |
0.0008 |
| 322 |
APGAR SCORE LOW |
1 |
0.0008 |
| 323 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 324 |
REHABILITATION THERAPY |
3 |
0.0008 |
| 325 |
INCOHERENT |
5 |
0.0008 |
| 326 |
MOOD ALTERED |
21 |
0.0008 |
| 327 |
SEXUAL DYSFUNCTION |
9 |
0.0008 |
| 328 |
COMPARTMENT SYNDROME |
2 |
0.0008 |
| 329 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 330 |
BRADYPHRENIA |
5 |
0.0008 |
| 331 |
FOREIGN BODY IN RESPIRATORY TRACT |
1 |
0.0008 |
| 332 |
POLYDIPSIA |
3 |
0.0008 |
| 333 |
PERSONALITY CHANGE |
7 |
0.0008 |
| 334 |
YAWNING |
2 |
0.0007 |
| 335 |
ALCOHOL POISONING |
2 |
0.0007 |
| 336 |
OVERWEIGHT |
4 |
0.0007 |
| 337 |
WEIGHT BEARING DIFFICULTY |
2 |
0.0007 |
| 338 |
SUICIDAL IDEATION |
68 |
0.0007 |
| 339 |
WRONG PATIENT RECEIVED MEDICATION |
2 |
0.0007 |
| 340 |
AGORAPHOBIA |
1 |
0.0007 |
| 341 |
HEAD TITUBATION |
1 |
0.0007 |
| 342 |
PSYCHOMOTOR HYPERACTIVITY |
12 |
0.0007 |
| 343 |
DRUG SCREEN FALSE POSITIVE |
2 |
0.0007 |
| 344 |
AUDITORY DISORDER |
1 |
0.0007 |
| 345 |
MENTAL IMPAIRMENT |
17 |
0.0007 |
| 346 |
ALCOHOLISM |
3 |
0.0007 |
| 347 |
FAT TISSUE INCREASED |
1 |
0.0007 |
| 348 |
METABOLIC DISORDER |
4 |
0.0007 |
| 349 |
BRADYKINESIA |
4 |
0.0007 |
| 350 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 351 |
APRAXIA |
1 |
0.0007 |
| 352 |
INTELLECTUAL DISABILITY |
1 |
0.0007 |
| 353 |
HEAT STROKE |
1 |
0.0007 |
| 354 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0007 |
| 355 |
TENSION |
4 |
0.0007 |
| 356 |
INJECTION SITE SWELLING |
50 |
0.0007 |
| 357 |
DISTURBANCE IN ATTENTION |
35 |
0.0006 |
| 358 |
FAMILY STRESS |
2 |
0.0006 |
| 359 |
MENTAL DISORDER |
28 |
0.0006 |
| 360 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 361 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 362 |
FEELING JITTERY |
12 |
0.0006 |
| 363 |
DEPRESSED MOOD |
33 |
0.0006 |
| 364 |
GALACTORRHOEA |
4 |
0.0006 |
| 365 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
1 |
0.0006 |
| 366 |
RASH VESICULAR |
3 |
0.0006 |
| 367 |
MUSCLE TIGHTNESS |
10 |
0.0006 |
| 368 |
PARKINSONISM |
6 |
0.0006 |
| 369 |
SOMNAMBULISM |
4 |
0.0006 |
| 370 |
INJECTION SITE INFECTION |
2 |
0.0006 |
| 371 |
CRYING |
22 |
0.0006 |
| 372 |
ILLUSION |
1 |
0.0006 |
| 373 |
EXTRAPYRAMIDAL DISORDER |
15 |
0.0006 |
| 374 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 375 |
TREMOR |
100 |
0.0006 |
| 376 |
EDUCATIONAL PROBLEM |
1 |
0.0006 |
| 377 |
PRODUCT SOLUBILITY ABNORMAL |
3 |
0.0006 |
| 378 |
WOUND DEHISCENCE |
2 |
0.0006 |
| 379 |
FOOD AVERSION |
1 |
0.0006 |
| 380 |
PRODUCT PREPARATION ERROR |
12 |
0.0006 |
| 381 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 382 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
41 |
0.0006 |
| 383 |
COORDINATION ABNORMAL |
8 |
0.0006 |
| 384 |
BREAST DISCHARGE |
1 |
0.0006 |
| 385 |
FOOD CRAVING |
3 |
0.0006 |
| 386 |
DRUG SCREEN NEGATIVE |
1 |
0.0006 |
| 387 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 388 |
MOOD SWINGS |
18 |
0.0006 |
| 389 |
BEHAVIOUR DISORDER |
3 |
0.0006 |
| 390 |
TONGUE DISORDER |
4 |
0.0006 |
| 391 |
ANXIETY |
156 |
0.0005 |
| 392 |
DRUG DOSE TITRATION NOT PERFORMED |
1 |
0.0005 |
| 393 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 394 |
HOMICIDE |
1 |
0.0005 |
| 395 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
110 |
0.0005 |
| 396 |
ARTHROPOD BITE |
4 |
0.0005 |
| 397 |
FEELING DRUNK |
4 |
0.0005 |
| 398 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 399 |
GENERAL SYMPTOM |
4 |
0.0005 |
| 400 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
95 |
0.0005 |
| 401 |
NEUROLOGICAL SYMPTOM |
3 |
0.0005 |
| 402 |
AFFECT LABILITY |
5 |
0.0005 |
| 403 |
DEPRESSION |
118 |
0.0005 |
| 404 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
2 |
0.0005 |
| 405 |
THERAPEUTIC RESPONSE DECREASED |
31 |
0.0005 |
| 406 |
COLOSTOMY |
1 |
0.0005 |
| 407 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 408 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 409 |
SYMPTOM RECURRENCE |
3 |
0.0005 |
| 410 |
INJECTION SITE HAEMORRHAGE |
40 |
0.0005 |
| 411 |
CARDIAC DISCOMFORT |
1 |
0.0005 |
| 412 |
INJECTION SITE VESICLES |
3 |
0.0005 |
| 413 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 414 |
INTENTIONAL SELF-INJURY |
10 |
0.0005 |
| 415 |
PRESYNCOPE |
12 |
0.0005 |
| 416 |
INJURY ASSOCIATED WITH DEVICE |
10 |
0.0005 |
| 417 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 418 |
MENSTRUAL DISORDER |
4 |
0.0005 |
| 419 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 420 |
MIDDLE INSOMNIA |
9 |
0.0005 |
| 421 |
INSULIN RESISTANCE |
1 |
0.0005 |
| 422 |
SOMNOLENCE |
96 |
0.0005 |
| 423 |
BLEPHAROSPASM |
3 |
0.0005 |
| 424 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
0.0005 |
| 425 |
MUSCULOSKELETAL DISCOMFORT |
8 |
0.0005 |
| 426 |
DYSTONIA |
9 |
0.0005 |
| 427 |
LANGUAGE DISORDER |
1 |
0.0005 |
| 428 |
NERVOUSNESS |
24 |
0.0005 |
| 429 |
ACCIDENT AT WORK |
1 |
0.0005 |
| 430 |
APPETITE DISORDER |
3 |
0.0005 |
| 431 |
LETHARGY |
26 |
0.0005 |
| 432 |
FEAR |
12 |
0.0004 |
| 433 |
FEAR OF DEATH |
1 |
0.0004 |
| 434 |
PANIC ATTACK |
16 |
0.0004 |
| 435 |
INJECTION SITE BRUISING |
35 |
0.0004 |
| 436 |
FEELING ABNORMAL |
105 |
0.0004 |
| 437 |
IMPLANT SITE INFECTION |
1 |
0.0004 |
| 438 |
DISCOURAGEMENT |
1 |
0.0004 |
| 439 |
INGROWING NAIL |
1 |
0.0004 |
| 440 |
SLEEP APNOEA SYNDROME |
8 |
0.0004 |
| 441 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0004 |
| 442 |
PANIC REACTION |
3 |
0.0004 |
| 443 |
BREATH ODOUR |
1 |
0.0004 |
| 444 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 445 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0004 |
| 446 |
DERMAL CYST |
1 |
0.0004 |
| 447 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 448 |
ACUTE PSYCHOSIS |
1 |
0.0004 |
| 449 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 450 |
BREAST TENDERNESS |
3 |
0.0004 |
| 451 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
19 |
0.0004 |
| 452 |
INSOMNIA |
105 |
0.0004 |
| 453 |
DRUG DOSE OMISSION |
65 |
0.0004 |
| 454 |
DRUG LEVEL DECREASED |
4 |
0.0004 |
| 455 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
14 |
0.0004 |
| 456 |
DISSOCIATION |
3 |
0.0004 |
| 457 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 458 |
DRUG TITRATION ERROR |
1 |
0.0004 |
| 459 |
INTENTIONAL DOSE OMISSION |
11 |
0.0004 |
| 460 |
HERNIA REPAIR |
1 |
0.0004 |
| 461 |
SLEEP DISORDER |
27 |
0.0004 |
| 462 |
NO ADVERSE EVENT |
69 |
0.0004 |
| 463 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 464 |
SUICIDE ATTEMPT |
23 |
0.0004 |
| 465 |
FOOD POISONING |
2 |
0.0004 |
| 466 |
BRUXISM |
2 |
0.0004 |
| 467 |
ANORGASMIA |
1 |
0.0004 |
| 468 |
INJECTION SITE REACTION |
25 |
0.0004 |
| 469 |
INJECTION SITE INJURY |
2 |
0.0004 |
| 470 |
DISCOMFORT |
22 |
0.0004 |
| 471 |
ROAD TRAFFIC ACCIDENT |
15 |
0.0004 |
| 472 |
MASS |
5 |
0.0004 |
| 473 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 474 |
ACCIDENTAL OVERDOSE |
13 |
0.0004 |
| 475 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
1 |
0.0004 |
| 476 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 477 |
DRUG ABUSE |
29 |
0.0003 |
| 478 |
MUSCLE STRAIN |
3 |
0.0003 |
| 479 |
SKIN SWELLING |
3 |
0.0003 |
| 480 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 481 |
SPEECH DISORDER |
18 |
0.0003 |
| 482 |
MUSCULOSKELETAL STIFFNESS |
30 |
0.0003 |
| 483 |
HEAD DISCOMFORT |
6 |
0.0003 |
| 484 |
URINARY INCONTINENCE |
10 |
0.0003 |
| 485 |
WRONG DRUG ADMINISTERED |
3 |
0.0003 |
| 486 |
PRODUCT PRESCRIBING ERROR |
8 |
0.0003 |
| 487 |
MYOCLONUS |
4 |
0.0003 |
| 488 |
MUSCLE RIGIDITY |
4 |
0.0003 |
| 489 |
THERAPEUTIC RESPONSE UNEXPECTED |
15 |
0.0003 |
| 490 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 491 |
EXPIRED PRODUCT ADMINISTERED |
11 |
0.0003 |
| 492 |
EMERGENCY CARE |
1 |
0.0003 |
| 493 |
INSURANCE ISSUE |
5 |
0.0003 |
| 494 |
BLOOD GLUCOSE ABNORMAL |
6 |
0.0003 |
| 495 |
BRAIN DEATH |
1 |
0.0003 |
| 496 |
DYSARTHRIA |
12 |
0.0003 |
| 497 |
PRODUCT PACKAGING ISSUE |
3 |
0.0003 |
| 498 |
THERAPEUTIC RESPONSE CHANGED |
2 |
0.0003 |
| 499 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 500 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
2 |
0.0003 |
| 501 |
CHOKING |
6 |
0.0003 |
| 502 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 503 |
THERAPY CHANGE |
3 |
0.0003 |
| 504 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 505 |
WALKING AID USER |
2 |
0.0003 |
| 506 |
ANXIETY DISORDER |
1 |
0.0003 |
| 507 |
DRUG EFFECT DECREASED |
16 |
0.0003 |
| 508 |
LIMB INJURY |
8 |
0.0003 |
| 509 |
MOTOR DYSFUNCTION |
3 |
0.0003 |
| 510 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 511 |
PALLOR |
8 |
0.0003 |
| 512 |
SCAR |
5 |
0.0003 |
| 513 |
AMNESIA |
19 |
0.0003 |
| 514 |
HEPATIC FIBROSIS |
1 |
0.0003 |
| 515 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
13 |
0.0003 |
| 516 |
GRANULOMA |
1 |
0.0003 |
| 517 |
HYPOPNOEA |
1 |
0.0003 |
| 518 |
POLLAKIURIA |
12 |
0.0003 |
| 519 |
FORMICATION |
2 |
0.0003 |
| 520 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 521 |
POOR QUALITY PRODUCT ADMINISTERED |
3 |
0.0003 |
| 522 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 523 |
IMPAIRED WORK ABILITY |
6 |
0.0003 |
| 524 |
DEVICE PLACEMENT ISSUE |
1 |
0.0003 |
| 525 |
APPARENT DEATH |
1 |
0.0003 |
| 526 |
BACK INJURY |
3 |
0.0003 |
| 527 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 528 |
DEVICE KINK |
1 |
0.0003 |
| 529 |
HYPOPHAGIA |
7 |
0.0003 |
| 530 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 531 |
FOOT DEFORMITY |
3 |
0.0003 |
| 532 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 533 |
ECONOMIC PROBLEM |
4 |
0.0003 |
| 534 |
MEMORY IMPAIRMENT |
36 |
0.0003 |
| 535 |
DEVICE PHYSICAL PROPERTY ISSUE |
2 |
0.0003 |
| 536 |
FEELING HOT |
16 |
0.0003 |
| 537 |
NIGHTMARE |
9 |
0.0003 |
| 538 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 539 |
CONCUSSION |
2 |
0.0003 |
| 540 |
INJECTION SITE ERYTHEMA |
32 |
0.0003 |
| 541 |
CERVIX CARCINOMA |
1 |
0.0003 |
| 542 |
ABNORMAL DREAMS |
7 |
0.0003 |
| 543 |
CONDITION AGGRAVATED |
77 |
0.0003 |
| 544 |
SCIATICA |
4 |
0.0003 |
| 545 |
SENSORY LOSS |
2 |
0.0002 |
| 546 |
ENURESIS |
1 |
0.0002 |
| 547 |
EXTRA DOSE ADMINISTERED |
10 |
0.0002 |
| 548 |
MALAISE |
108 |
0.0002 |
| 549 |
HICCUPS |
2 |
0.0002 |
| 550 |
SEIZURE |
28 |
0.0002 |
| 551 |
MUSCLE INJURY |
2 |
0.0002 |
| 552 |
INJECTION SITE DISCOLOURATION |
3 |
0.0002 |
| 553 |
GAIT INABILITY |
8 |
0.0002 |
| 554 |
ERECTION INCREASED |
1 |
0.0002 |
| 555 |
INJECTION SITE IRRITATION |
3 |
0.0002 |
| 556 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 557 |
HEPATIC PAIN |
1 |
0.0002 |
| 558 |
DRY MOUTH |
19 |
0.0002 |
| 559 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 560 |
BONE CANCER |
1 |
0.0002 |
| 561 |
GAIT DISTURBANCE |
44 |
0.0002 |
| 562 |
PRODUCT COMMUNICATION ISSUE |
2 |
0.0002 |
| 563 |
ADVERSE REACTION |
3 |
0.0002 |
| 564 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 565 |
SWOLLEN TONGUE |
7 |
0.0002 |
| 566 |
MUSCLE SPASMS |
41 |
0.0002 |
| 567 |
DRUG EFFECT DELAYED |
1 |
0.0002 |
| 568 |
DRUG EFFECT INCOMPLETE |
8 |
0.0002 |
| 569 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0002 |
| 570 |
MENTAL STATUS CHANGES |
6 |
0.0002 |
| 571 |
DEMENTIA |
6 |
0.0002 |
| 572 |
BLOOD CHOLESTEROL INCREASED |
10 |
0.0002 |
| 573 |
PRODUCT DOSE OMISSION ISSUE |
62 |
0.0002 |
| 574 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 575 |
HYPERHIDROSIS |
27 |
0.0002 |
| 576 |
PARALYSIS |
3 |
0.0002 |
| 577 |
ACCIDENTAL UNDERDOSE |
3 |
0.0002 |
| 578 |
DRUG INEFFECTIVE |
272 |
0.0002 |
| 579 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 580 |
FIBROMYALGIA |
5 |
0.0002 |
| 581 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 582 |
DISABILITY |
4 |
0.0002 |
| 583 |
FOOT OPERATION |
1 |
0.0002 |
| 584 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 585 |
ANEURYSM |
1 |
0.0002 |
| 586 |
HYPOTONIA |
2 |
0.0002 |
| 587 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 588 |
SALIVARY HYPERSECRETION |
2 |
0.0002 |
| 589 |
VAGINAL DISCHARGE |
2 |
0.0002 |
| 590 |
DRUG TOLERANCE |
1 |
0.0002 |
| 591 |
DYSPHORIA |
1 |
0.0002 |
| 592 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 593 |
FATIGUE |
153 |
0.0002 |
| 594 |
TOOTH ABSCESS |
2 |
0.0002 |
| 595 |
MOBILITY DECREASED |
14 |
0.0002 |
| 596 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 597 |
ANKLE FRACTURE |
3 |
0.0002 |
| 598 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 599 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 600 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
5 |
0.0002 |
| 601 |
WITHDRAWAL SYNDROME |
8 |
0.0002 |
| 602 |
RENAL PAIN |
2 |
0.0002 |
| 603 |
EATING DISORDER |
4 |
0.0002 |
| 604 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 605 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 606 |
HIP SURGERY |
1 |
0.0002 |
| 607 |
ILLNESS |
19 |
0.0002 |
| 608 |
ACCIDENTAL EXPOSURE TO PRODUCT |
19 |
0.0002 |
| 609 |
OESOPHAGITIS |
2 |
0.0002 |
| 610 |
JAW DISORDER |
1 |
0.0002 |
| 611 |
FAECALOMA |
1 |
0.0002 |
| 612 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 613 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 614 |
DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0002 |
| 615 |
HYPERKERATOSIS |
1 |
0.0002 |
| 616 |
PRODUCT USE ISSUE |
34 |
0.0002 |
| 617 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 618 |
GRANULOCYTOPENIA |
1 |
0.0002 |
| 619 |
MICTURITION URGENCY |
2 |
0.0002 |
| 620 |
HYPOAESTHESIA |
26 |
0.0002 |
| 621 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 622 |
EMOTIONAL DISTRESS |
21 |
0.0002 |
| 623 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 624 |
DYSSTASIA |
5 |
0.0002 |
| 625 |
AMENORRHOEA |
3 |
0.0002 |
| 626 |
SPLENOMEGALY |
2 |
0.0002 |
| 627 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 628 |
DIABETES MELLITUS |
13 |
0.0002 |
| 629 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 630 |
ACCIDENT |
2 |
0.0002 |
| 631 |
DEVICE ISSUE |
15 |
0.0002 |
| 632 |
BLOOD PRESSURE FLUCTUATION |
4 |
0.0002 |
| 633 |
GANGRENE |
1 |
0.0002 |
| 634 |
TOOTHACHE |
3 |
0.0002 |
| 635 |
HEPATITIS C |
2 |
0.0002 |
| 636 |
INJECTION SITE RASH |
5 |
0.0002 |
| 637 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 638 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 639 |
UNEVALUABLE EVENT |
12 |
0.0002 |
| 640 |
DYSPHAGIA |
15 |
0.0002 |
| 641 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 642 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
| 643 |
MIGRAINE |
15 |
0.0002 |
| 644 |
DIZZINESS |
78 |
0.0002 |
| 645 |
MYDRIASIS |
2 |
0.0002 |
| 646 |
MOVEMENT DISORDER |
5 |
0.0002 |
| 647 |
RASH GENERALISED |
4 |
0.0002 |
| 648 |
HYPERPROLACTINAEMIA |
1 |
0.0002 |
| 649 |
PALPITATIONS |
18 |
0.0002 |
| 650 |
VISION BLURRED |
21 |
0.0002 |
| 651 |
ANHEDONIA |
4 |
0.0002 |
| 652 |
BEDRIDDEN |
2 |
0.0002 |
| 653 |
DYSGRAPHIA |
1 |
0.0002 |
| 654 |
PRESCRIBED UNDERDOSE |
3 |
0.0002 |
| 655 |
ABORTION SPONTANEOUS |
6 |
0.0001 |
| 656 |
PAIN IN EXTREMITY |
44 |
0.0001 |
| 657 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 658 |
BREAST MASS |
1 |
0.0001 |
| 659 |
CONFUSIONAL STATE |
24 |
0.0001 |
| 660 |
DECREASED APPETITE |
34 |
0.0001 |
| 661 |
ENCEPHALITIS |
1 |
0.0001 |
| 662 |
APHONIA |
2 |
0.0001 |
| 663 |
EXTRASYSTOLES |
1 |
0.0001 |
| 664 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 665 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 666 |
HAND FRACTURE |
1 |
0.0001 |
| 667 |
JOINT INJURY |
3 |
0.0001 |
| 668 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 669 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 670 |
CELLULITIS |
7 |
0.0001 |
| 671 |
INJECTION SITE HAEMATOMA |
2 |
0.0001 |
| 672 |
HYPOKINESIA |
2 |
0.0001 |
| 673 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 674 |
GASTROENTERITIS |
2 |
0.0001 |
| 675 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 676 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 677 |
MATERNAL EXPOSURE DURING PREGNANCY |
12 |
0.0001 |
| 678 |
DRUG INTOLERANCE |
13 |
0.0001 |
| 679 |
INFLUENZA LIKE ILLNESS |
11 |
0.0001 |
| 680 |
CHROMATURIA |
3 |
0.0001 |
| 681 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 682 |
VOMITING |
62 |
0.0001 |
| 683 |
ILL-DEFINED DISORDER |
8 |
0.0001 |
| 684 |
HYPERTHERMIA |
1 |
0.0001 |
| 685 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 686 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 687 |
THYROID DISORDER |
2 |
0.0001 |
| 688 |
APHTHOUS ULCER |
1 |
0.0001 |
| 689 |
APNOEA |
1 |
0.0001 |
| 690 |
CYANOSIS |
2 |
0.0001 |
| 691 |
HEAD INJURY |
4 |
0.0001 |
| 692 |
FURUNCLE |
1 |
0.0001 |
| 693 |
DISORIENTATION |
5 |
0.0001 |
| 694 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 695 |
DRUG INTERACTION |
20 |
0.0001 |
| 696 |
OBESITY |
2 |
0.0001 |
| 697 |
ABSCESS |
2 |
0.0001 |
| 698 |
BLOOD DISORDER |
1 |
0.0001 |
| 699 |
BACK DISORDER |
2 |
0.0001 |
| 700 |
WEIGHT DECREASED |
34 |
0.0001 |
| 701 |
HYPERAESTHESIA |
1 |
0.0001 |
| 702 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 703 |
AGEUSIA |
3 |
0.0001 |
| 704 |
DRY EYE |
6 |
0.0001 |
| 705 |
COMPLETED SUICIDE |
10 |
0.0001 |
| 706 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 707 |
SYNCOPE |
12 |
0.0001 |
| 708 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 709 |
FACE OEDEMA |
2 |
0.0001 |
| 710 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 711 |
NAUSEA |
93 |
0.0001 |
| 712 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 713 |
HYSTERECTOMY |
1 |
0.0001 |
| 714 |
DEVICE LEAKAGE |
5 |
0.0001 |
| 715 |
JOINT STIFFNESS |
3 |
0.0001 |
| 716 |
PRODUCT STORAGE ERROR |
10 |
0.0001 |
| 717 |
GROIN PAIN |
1 |
0.0001 |
| 718 |
COLD SWEAT |
2 |
0.0001 |
| 719 |
VISUAL IMPAIRMENT |
14 |
0.0001 |
| 720 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
0.0001 |
| 721 |
TACHYCARDIA |
10 |
0.0001 |
| 722 |
FACIAL PAIN |
1 |
0.0001 |
| 723 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 724 |
HEART RATE INCREASED |
11 |
0.0001 |
| 725 |
PELVIC PAIN |
2 |
0.0001 |
| 726 |
BONE DISORDER |
2 |
0.0001 |
| 727 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 728 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 729 |
BACK PAIN |
25 |
0.0001 |
| 730 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 731 |
WOUND |
3 |
0.0001 |
| 732 |
ABDOMINAL DISCOMFORT |
18 |
0.0001 |
| 733 |
PHOTOPHOBIA |
2 |
0.0001 |
| 734 |
HOT FLUSH |
8 |
0.0001 |
| 735 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 736 |
PAIN IN JAW |
3 |
0.0001 |
| 737 |
FRACTURE |
2 |
0.0001 |
| 738 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 739 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 740 |
BALANCE DISORDER |
9 |
0.0001 |
| 741 |
PERIPHERAL SWELLING |
16 |
0.0001 |
| 742 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 743 |
NASOPHARYNGITIS |
19 |
0.0001 |
| 744 |
COELIAC DISEASE |
1 |
0.0001 |
| 745 |
KIDNEY INFECTION |
2 |
0.0001 |
| 746 |
MENORRHAGIA |
2 |
0.0001 |
| 747 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 748 |
BLADDER DISORDER |
1 |
0.0001 |
| 749 |
MYALGIA |
17 |
0.0001 |
| 750 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 751 |
PREMATURE BABY |
3 |
0.0001 |
| 752 |
APHASIA |
3 |
0.0001 |
| 753 |
FEEDING DISORDER |
2 |
0.0001 |
| 754 |
DEVICE BREAKAGE |
4 |
0.0001 |
| 755 |
DRY THROAT |
1 |
0.0001 |
| 756 |
BLOOD PRESSURE INCREASED |
15 |
0.0001 |
| 757 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 758 |
EAR DISCOMFORT |
1 |
0.0001 |
| 759 |
RIB FRACTURE |
2 |
0.0001 |
| 760 |
FEMUR FRACTURE |
3 |
0.0001 |
| 761 |
TREATMENT FAILURE |
8 |
0.0001 |
| 762 |
EYE DISCHARGE |
1 |
0.0001 |
| 763 |
ARTHRALGIA |
40 |
0.0001 |
| 764 |
FOLLICULITIS |
1 |
0.0001 |
| 765 |
MOUTH ULCERATION |
2 |
0.0001 |
| 766 |
JOINT DISLOCATION |
1 |
0.0001 |
| 767 |
HYPERTENSION |
20 |
0.0001 |
| 768 |
BRADYCARDIA |
5 |
0.0001 |
| 769 |
RETCHING |
2 |
0.0001 |
| 770 |
LOSS OF CONSCIOUSNESS |
12 |
0.0001 |
| 771 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 772 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 773 |
ABDOMINAL PAIN UPPER |
19 |
0.0001 |
| 774 |
SWELLING FACE |
6 |
0.0001 |
| 775 |
CHOLELITHIASIS |
3 |
0.0001 |
| 776 |
IMPAIRED HEALING |
3 |
0.0001 |
| 777 |
ASPIRATION |
1 |
0.0001 |
| 778 |
TOOTH DISORDER |
2 |
0.0001 |
| 779 |
INJECTION SITE PRURITUS |
6 |
0.0001 |
| 780 |
HEADACHE |
56 |
0.0001 |
| 781 |
SNEEZING |
2 |
0.0001 |
| 782 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 783 |
EYE PAIN |
5 |
0.0001 |
| 784 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 785 |
MUSCULAR WEAKNESS |
10 |
0.0001 |
| 786 |
ASTHENIA |
33 |
0.0001 |
| 787 |
CONSTIPATION |
19 |
0.0001 |
| 788 |
TINNITUS |
4 |
0.0001 |
| 789 |
PAIN |
53 |
0.0001 |
| 790 |
INJURY |
6 |
0.0001 |
| 791 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 792 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 793 |
ATAXIA |
1 |
0.0001 |
| 794 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 795 |
BURSITIS |
1 |
0.0001 |
| 796 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 797 |
FALL |
27 |
0.0001 |
| 798 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 799 |
CYST |
1 |
0.0001 |
| 800 |
BLOOD GLUCOSE INCREASED |
15 |
0.0001 |
| 801 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 802 |
FLUID RETENTION |
4 |
0.0001 |
| 803 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 804 |
PYREXIA |
27 |
0.0001 |
| 805 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 806 |
URTICARIA |
13 |
0.0001 |
| 807 |
SKIN ULCER |
2 |
0.0001 |
| 808 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 809 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 810 |
DYSMENORRHOEA |
1 |
0.0001 |
| 811 |
HYPERSENSITIVITY |
14 |
0.0001 |
| 812 |
DEHYDRATION |
10 |
0.0001 |
| 813 |
SWELLING |
7 |
0.0001 |
| 814 |
HYPOTENSION |
15 |
0.0001 |
| 815 |
MENSTRUATION IRREGULAR |
2 |
0.0001 |
| 816 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 817 |
PRODUCT QUALITY ISSUE |
10 |
0.0001 |
| 818 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 819 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 820 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 821 |
BURNING SENSATION |
5 |
0.0001 |
| 822 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 823 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 824 |
DIALYSIS |
1 |
0.0001 |
| 825 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 826 |
ANGINA PECTORIS |
2 |
0.0001 |
| 827 |
EYE IRRITATION |
4 |
0.0001 |
| 828 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 829 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 830 |
DYSPHONIA |
4 |
0.0001 |
| 831 |
BONE PAIN |
4 |
0.0001 |
| 832 |
NASAL CONGESTION |
4 |
0.0001 |
| 833 |
EPISTAXIS |
5 |
0.0001 |
| 834 |
JOINT SWELLING |
8 |
0.0001 |
| 835 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 836 |
ACNE |
5 |
0.0001 |
| 837 |
VERTIGO |
4 |
0.0001 |
| 838 |
SKIN IRRITATION |
3 |
0.0001 |
| 839 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 840 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 841 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 842 |
ADVERSE EVENT |
6 |
0.0001 |
| 843 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 844 |
GYNAECOMASTIA |
2 |
0.0001 |
| 845 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 846 |
BRAIN FOG |
1 |
0.0001 |
| 847 |
PARAESTHESIA |
10 |
0.0001 |
| 848 |
HIP FRACTURE |
2 |
0.0001 |
| 849 |
THROMBOSIS |
5 |
0.0001 |
| 850 |
ALOPECIA |
12 |
0.0001 |
| 851 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 852 |
PRODUCT USE IN UNAPPROVED INDICATION |
15 |
0.0001 |
| 853 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 854 |
BLOOD PRESSURE DECREASED |
4 |
0.0001 |
| 855 |
DYSPNOEA |
34 |
0.0001 |
| 856 |
LIP SWELLING |
2 |
0.0001 |
| 857 |
COAGULOPATHY |
1 |
0.0001 |
| 858 |
FUNGAL INFECTION |
2 |
0.0001 |
| 859 |
URINARY RETENTION |
2 |
0.0001 |
| 860 |
CHILLS |
7 |
0.0001 |
| 861 |
CHEST PAIN |
11 |
0.0001 |
| 862 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 863 |
THERAPY CESSATION |
3 |
0.0001 |
| 864 |
HAEMATURIA |
2 |
0.0001 |
| 865 |
ERYTHEMA |
12 |
0.0001 |
| 866 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 867 |
DELIRIUM |
2 |
0.0001 |
| 868 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 869 |
HEART RATE DECREASED |
2 |
0.0001 |
| 870 |
PANCREATITIS |
3 |
0.0001 |
| 871 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 872 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 873 |
DYSURIA |
2 |
0.0001 |
| 874 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 875 |
DYSGEUSIA |
4 |
0.0001 |
| 876 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 877 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 878 |
FOOT FRACTURE |
1 |
0.0001 |
| 879 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 880 |
ERUCTATION |
1 |
0.0001 |
| 881 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 882 |
HAEMORRHOIDS |
1 |
0.0001 |
| 883 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 884 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 885 |
COMPLICATION OF DEVICE INSERTION |
1 |
0.0001 |
| 886 |
COUGH |
14 |
0.0000 |
| 887 |
FLUSHING |
5 |
0.0000 |
| 888 |
BLINDNESS |
2 |
0.0000 |
| 889 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 890 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 891 |
CEREBROVASCULAR ACCIDENT |
8 |
0.0000 |
| 892 |
OVERDOSE |
10 |
0.0000 |
| 893 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 894 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 895 |
MYOCARDIAL INFARCTION |
8 |
0.0000 |
| 896 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 897 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 898 |
DIARRHOEA |
29 |
0.0000 |
| 899 |
INFLUENZA |
5 |
0.0000 |
| 900 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 901 |
THROAT IRRITATION |
2 |
0.0000 |
| 902 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 903 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 904 |
DEATH |
37 |
0.0000 |
| 905 |
CARDIAC DISORDER |
4 |
0.0000 |
| 906 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 907 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 908 |
HEPATIC CANCER |
1 |
0.0000 |
| 909 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 910 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 911 |
LUNG DISORDER |
2 |
0.0000 |
| 912 |
DYSPEPSIA |
4 |
0.0000 |
| 913 |
ABASIA |
1 |
0.0000 |
| 914 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 915 |
GASTRIC CANCER |
1 |
0.0000 |
| 916 |
HAEMATEMESIS |
1 |
0.0000 |
| 917 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 918 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 919 |
HAEMATOMA |
1 |
0.0000 |
| 920 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 921 |
DIPLOPIA |
1 |
0.0000 |
| 922 |
GASTRITIS |
1 |
0.0000 |
| 923 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 924 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 925 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 926 |
RASH PRURITIC |
2 |
0.0000 |
| 927 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 928 |
OEDEMA |
2 |
0.0000 |
| 929 |
MEDICATION ERROR |
2 |
0.0000 |
| 930 |
FEELING COLD |
1 |
0.0000 |
| 931 |
HAEMOPTYSIS |
1 |
0.0000 |
| 932 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 933 |
BLISTER |
2 |
0.0000 |
| 934 |
HYPONATRAEMIA |
2 |
0.0000 |
| 935 |
ASTHMA |
4 |
0.0000 |
| 936 |
FLATULENCE |
2 |
0.0000 |
| 937 |
COVID-19 |
6 |
0.0000 |
| 938 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 939 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 940 |
SURGERY |
2 |
0.0000 |
| 941 |
PNEUMONIA |
11 |
0.0000 |
| 942 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 943 |
WHEEZING |
2 |
0.0000 |
| 944 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 945 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 946 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 947 |
PRURITUS |
12 |
0.0000 |
| 948 |
INTENTIONAL OVERDOSE |
2 |
0.0000 |
| 949 |
CONTUSION |
3 |
0.0000 |
| 950 |
DRUG DEPENDENCE |
5 |
0.0000 |
| 951 |
RHINORRHOEA |
2 |
0.0000 |
| 952 |
RENAL FAILURE |
4 |
0.0000 |
| 953 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 954 |
DEVICE MALFUNCTION |
2 |
0.0000 |
| 955 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 956 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 957 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 958 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 959 |
INFECTION |
4 |
0.0000 |
| 960 |
RASH |
12 |
0.0000 |
| 961 |
BRONCHITIS |
2 |
0.0000 |
| 962 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 963 |
RHEUMATOID ARTHRITIS |
3 |
0.0000 |
| 964 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 965 |
HYPOACUSIS |
1 |
0.0000 |
| 966 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 967 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 968 |
NEUTROPENIA |
3 |
0.0000 |
| 969 |
ARRHYTHMIA |
1 |
0.0000 |
| 970 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 971 |
COMA |
1 |
0.0000 |
| 972 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 973 |
SINUSITIS |
2 |
0.0000 |
| 974 |
INFLAMMATION |
1 |
0.0000 |
| 975 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 976 |
DEPENDENCE |
1 |
0.0000 |
| 977 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 978 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 979 |
SEPSIS |
2 |
0.0000 |
| 980 |
HERPES ZOSTER |
1 |
0.0000 |
| 981 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 982 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 983 |
PSORIASIS |
2 |
0.0000 |
| 984 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 985 |
DRY SKIN |
2 |
0.0000 |
| 986 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 987 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 988 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 989 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 990 |
HAEMORRHAGE |
1 |
0.0000 |
| 991 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 992 |
ANAEMIA |
1 |
0.0000 |